← back to search

Philip G. de Groot

Synapse (Netherlands) · NL
Area of research
Hematology · Rheumatology
Research interest
Research interests include Platelet Disorders and Treatments, Systemic Lupus Erythematosus Research, Blood Coagulation and Thrombosis Mechanisms, and Blood properties and coagulation.
h-index
87
citations
37,017
works
477
NIH funding
primary concept
email

Recent publications

2023 ACR/EULAR antiphospholipid syndrome classification criteria
Annals of the Rheumatic Diseases 2023cited by 398position: middledoi
Crucial roles of red blood cells and platelets in whole blood thrombin generation
Blood Advances 2023cited by 26position: middledoi
Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia
Cells 2021cited by 84position: middledoi
Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
Journal of Thrombosis and Haemostasis 2021cited by 40position: middledoi
Long-term treated HIV infection is associated with platelet mitochondrial dysfunction
Scientific Reports 2021cited by 27position: middledoi
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis 2020cited by 400position: middledoi
Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue
PLoS Pathogens 2019cited by 50position: middledoi
Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren
Journal of Helminthology 2019cited by 23position: middledoi
Antiphospholipid syndrome
Nature Reviews Disease Primers 2018cited by 347position: middledoi
New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
Haematologica 2018cited by 55position: middledoi
Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations
Journal of Allergy and Clinical Immunology 2016cited by 173position: middledoi
Shear-Resistant Binding to von Willebrand Factor Allows<i>Staphylococcus lugdunensis</i>to Adhere to the Cardiac Valves and Initiate Endocarditis
The Journal of Infectious Diseases 2016cited by 48position: middledoi
A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammation
Scientific Reports 2016cited by 26position: middledoi
ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice
Arthritis & Rheumatology 2015cited by 76position: middledoi
Is asymptomatic malaria really asymptomatic? Hematological, vascular and inflammatory effects of asymptomatic malaria parasitemia
Journal of Infection 2015cited by 65position: middledoi
Platelet‐reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta‐analysis
Journal of Thrombosis and Haemostasis 2014cited by 101position: middledoi
Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy
Circulation 2014cited by 85position: middledoi
Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets
Cardiovascular Research 2014cited by 76position: middledoi
FLow-Induced PRotrusions (FLIPRs)
Circulation Research 2014cited by 55position: middledoi
Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome
Blood 2014cited by 49position: middledoi
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow
PLoS ONE 2014cited by 47position: middledoi
Platelets as pivot in the antiphospholipid syndrome
Blood 2014cited by 18position: firstdoi
Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses
PLoS ONE 2013cited by 126position: middledoi
Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
PLoS ONE 2013cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark Roest · Utrecht University8 papers (2014–2023)Rolf T. Urbanus · Utrecht University7 papers (2014–2021)Coen Maas · Utrecht University4 papers (2014–2016)Gerard Pasterkamp · Norwegian Womens Public Health Association4 papers (2013–2016)Bas de Laat · Utrecht University4 papers (2013–2023)Quirijn de Mast · Radboud University Nijmegen3 papers (2015–2021) · 3 papers (2015–2021) · 2 papers (2013–2020)Vittorio Pengo · University of Padua2 papers (2013–2020)Johan W. M. Heemskerk · Leiden University Medical Center2 papers (2021–2023)Hugo Ten Cate · Maastricht University2 papers (2021–2023)Claudia Tersteeg · Utrecht University2 papers (2014–2014)Steven de Maat · Utrecht University2 papers (2014–2016)Thijs C. van Holten · Utrecht University2 papers (2013–2014)Arjan D. Barendrecht · Utrecht University2 papers (2014–2014)Imo E. Hoefer · Heidelberg University2 papers (2013–2014)Jane E. Salmon · Hospital for Special Surgery2 papers (2015–2018) · 2 papers (2018–2020)Arnold C. Koekman · Utrecht University2 papers (2014–2016) · 2 papers (2021–2023)